IJCRR - 6(9), May, 2014
Pages: 01-10
COMMUNITY-ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS
Author: Veni Emilda J. K., Shrikala Baliga, Shenoy M., Gopalkrishna Bhat K.
Category: General Sciences
[Download PDF]
Abstract:
Methicillin resistant S.aureus (MRSA) has emerged as an important pathogen first in hospitals and then in the community. Community - acquired MRSA (CA-MRSA) has recently emerged as a significant pathogen, mainly causing skin and soft tissue infections in immunocompetent individuals residing in the community. It may also cause serious infections such as pneumonia. Person to person spread of CA-MRSAoccurs mainly due to overcrowding, skin to skin contact, compromised skin integrity, sharingcontaminated materials and poor hygiene. Possession of staphylococcal cassette chromosome mec type IV (SCCmec IV) encoding for mecA gene, susceptibility to non β-lactam antibiotics and a pvl gene encoding Panton-Valentine Leukocidin (PVL) primarily distinguish CA-MRSA from healthcare-associated MRSA. In addition to PVL, CA-MRSA produces many other virulence factors which play important role in its pathogenicity.
Keywords: Community-acquired MRSA, Panton - Valentine Leukocidin, Staphylococcal cassette chromosome mec IV
Citation:
Veni Emilda J. K., Shrikala Baliga, Shenoy M., Gopalkrishna Bhat K.. COMMUNITY-ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS International Journal of Current Research and Review. 6(9), May, 01-10
References:
REFERENCES
1. Wijaya L, Hsu LY, Kurup A. Communityassociated methicillin-resistant Staphylococcus aureus: overview and local situation.Ann Acad Med Singapore 2006; 35:479-86.
2. Ray P, Goutam V, Singh R. Methicillinresistant Staphylococcus aureus (MRSA) in developing and developed countries: implications and solutions.Regional Health Forum 2011; 15:74-82.
3. Otto M. Community-associated MRSA: A dangerous epidemic. Future Microbiol 2007; 2:457-9.
4. Centers for Disease Control and Prevention. Four paediatric deaths from communityacquired methicillin-resistant Staphylococcus aureus – Minnesota and North Dakota, 1997- 1999. JAMA 1999; 282:1123-5.
5. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis2005; 5:275–86.
6. Shenoy MS, Bhat GK, Kishore A, Hassan MK. Significance of MRSA strains in community associated skin and soft tissue infections. Indian J Med Microbiol 2010; 28:152-4.
7. Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) - Fact Sheet. [Internet] Department of Health, New York. (Reviewed 2013). Available from: http://www.health.ny.gov/diseases/communica ble/staphylococcus_aureus/methicillin_resistant /community_associated/fact_sheet.htm
8. Diagnosis and Testing of MRSA Infections [Internet]. Centers for Disease Control and Prevention 2010 (updated 2010 December 02). Available from: http://www.cdc.gov/mrsa/diagnosis/index.html
9. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, et al. Communityacquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9:978–84.
10. O’Brien FG, Lim TT, Chong FN, Coombs GW, Enright MC, Robinson DA, et al. Diversity among community isolates of methicillinresistant Staphylococcus aureus in Australia. J Clin Microbiol 2004; 42:3185–90.
11. Krishna BV, Patil AB, Chandrasekhar MR. Community-acquired methicillin-resistant Staphylococcus aureus infections in a South Indian city. Southeast Asian J Trop Med Public Health 2004; 35:371-4.
12. Salgado CD, Farr BM, Calfee DP. Communityacquired methicillin-resistant Staphylococcus aureus: A meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 36:131–9.
13. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community- and health careassociated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290:2976–84.
14. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA, Participants in the CDC Convened Experts’ Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: Summary of an experts’ meeting convened by the Centers for Disease Control and Prevention.[Internet] 2006. Available at http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.ht ml.
15. Fritz SA, Epplin EK, Garbutt J, Storch GA. Skin infection in children colonized with community-associated methicillin-resistant Staphylococcus aureus. J Infect 2009; 59:394– 401.
16. Chatterjee SS, Ray P, Aggarwal A, Das A, Sharma M. A community-based study on nasal carriage of Staphylococcus aureus. Indian J Med Res 2009; 130:742-8.
17. Chua K, Laurent F, Coombs G, Grayson ML, Howden BP. Not community-associated methicillin resistant Staphylococcus aureus (CA-MRSA)!– A clinician’s guide to community MRSA- Its evolving antimicrobial resistance and implications for therapy. Clin Infect Dis 2011; 52:99-114.
18. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillinresistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763–71.
19. Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 2009; 64:441–6.
20. Hidron AI, Low CE, Honig EG, Blumberg HM. Emergence of community- acquired methicillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia. Lancet Infect Dis 2009; 9:384–92.
21. David MZ, Rudolph KM, Hennessy TW, Boyle-Vavra S, Daum RS. Molecular epidemiology of methicillin-resistant Staphylococcus aureus, rural southwestern Alaska. Emerg Infect Dis 2008; 14:1693–9.
22. Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Communityassociated methicillin-resistant Staphylococcus aureus isolates causing health care associated infections. Emerg Infect Dis 2007; 13:236-42.
23. Natarajaseenivasan K, Shanmughapriya S, Latha R, Artiflavia GB, Kanagavel M, Pragash DS. Prevalence of community acquired methicillin resistant Staphylococcus aureus (CA-MRSA) in skin and soft tissue infections among cases from Puducherry, India. J Public Health 2012; 20:593-7.
24. Nagaraju U, Bhat G, Kuruvila M, Pai GS, Jayalakshmi, Babu RP. Methicillin-resistant Staphylococcus aureus in community-acquired pyoderma. Int J Dermatol 2004; 43:412-4.
25. Song JH, Hsueh PR, Chung DR, Ko KS, Kang CI, Peck KR, et al: ANSORP study group. Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study. J Antimicrob Chemother 2011; 66:1061- 9.
26. Humphreys H. Staphylococcus. Greenwood D, Barer M, Richard S, Irving W editors. Medical Microbiology. A guide to microbial infection: Pathogenesis, immunity, laboratory investigation and control. 18th edition. Churchill livingstone.
27. Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46:350–9.
28. Schlievert PM, Stransberd KL, Lin Y, Peterson ML, Leung DYM. Secreted virulence factor comparison between methicillin resistant and methicillin sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 2010; 125:39-49.
29. Elasri MO, Thomas JR, Skinner RA, Blevins JS, Beenken KE, Nelson CL, et al. Staphylococcus aureus collagen adhesin contributes to the pathogenesis of osteomyelitis. Bone2002; 30:275–80.
30. Patti JM, Bremell T, Krajewska-Pietrasik D, Abdelnour A, Tarkowski A , Ryden C, et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun1994; 62:152–61.
31. Tzianabos AO, Wang JY, Lee JC. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc Natl Acad Sci U S A 2001; 98:9365–70.
32. Miller M, Bassler B. Quorum sensing in bacteria. Annu Rev Microbiol2001; 55:165–99.
33. Watkins RR, David MZ, Salata RA. Current concepts on the virulence mechanisms of methicillin-resistant Staphylococcus aureus. J Med Microbiol 2012; 61:1179-93.
34. Genestier AL, Michallet MC, Pre´ vost, G, Bellot G, Chalabreysse L, Peyrol S, et al. Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 2005; 115:3117–27.
35. O’Hara FP, Guex N, Word JM, Miller LA, Becker JA, Walsh SL, et al. A geographic variant of the Staphylococcus aureus PantonValentine leukocidin toxin and the origin of community-associated methicillin-resistant S.aureus USA300. J Infect Dis 2008; 197:187– 94.
36. Bae IG, Tonthat GT, Stryjewski ME, Rude T H, Reilly LF, Barriere SL, et al. Presence of genes encoding the Panton-Valentine leukocidin exotoxins is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin resistant Staphylococcus aureus: results of a multinational trial. J Clin Microbiol 2009; 47:3952–7.
37. Dumitrescu O, Choudhury P, Boisset S, Badiou C, Bes M, Benito Y, et al. Beta-lactams interfering with PBP1 induce Panton-Valentine leukocidin expression by triggering sarA and rot global regulators of Staphylococcus aureus. Antimicrob Agents Chemother 2011; 55:3261– 71.
38. Rybak MJ, LaPlante KL. Communityassociated methicillin-resistant Staphylococcus aureus: A review. Pharmacotherapy 2005; 25:74-85.
39. Yamaguchi T, Yokota Y, Terajima J, Hayashi T, Aepfelbacher M, Ohara M, et al. Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. J Infect Dis2002; 185:1511-6.
40. Hartman B, Tomasz A. Altered penicillinbinding proteins in methicillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother 1981; 19:726-35.
41. Teruyo Ito. International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC). Classification of Staphylococcal cassette chromosome mec (Sccmec): Guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother 2009; 53:4961–7.
42. Berglund C, Mo¨lling P, Sjo¨berg L, So¨derquist B. Predominance of staphylococcal cassette chromosome mec (SCCmec) type IV among methicillin-resistant Staphylococcus aureus (MRSA) in a Swedish county and presence of unknown SCCmec types with Panton-Valentine leukocidin genes. Clin Microbiol Infect 2005; 11: 447–56.
43. Mongkolrattanothai K, Boyle S, Murphy TV, Daum RS. Novel non-mecA containing staphylococcal chromosomal cassette composite island containing pbp4 and tagF genes in a commensal staphylococcal species: a possible reservoir for antibiotic resistance islands in Staphylococcus aureus. Antimicrob Agents Chemother2004; 48:1823–36.
44. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O’Brien FG, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol2002; 40: 4289–94.
45. Kilic A, Li H, Stratton CW, Tang YW. Antimicrobial susceptibility patterns and staphylococcal cassette chromosome mec types of, as well as panton valentine leukocidin occurrence among methicillin-resistant Staphylococcus aureus isolates from children and adults in Middle Tennessee. J Clin Microbiol 2006; 44:4336-40.
46. Mandelia C, Shenoy S. Community associated-methicillin resistant Staphylococcus aureus in skin and soft tissue infections. J Clin Diagn Res 2010; 4:2673-7.
47. Liassine N, Auckenthaler R, Descombes MC, Bes M, Vandenesch F, Etienne J. Communityacquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes. J Clin Microbiol2004; 42:825–8.
48. Takizawa Y, Taneike I, Nakagawa S, Oishi T, Nitahara Y, Iwakura N, et al. A PantonValentine leucocidin (PVL)-positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan. J Clin Microbiol 2005; 43:3356-63.
49. Lina G, Pie´mont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, et al. Involvement of Panton-Valentine Leukocidin– producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29:1128–32.
50. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, et al. Necrotizing fasciitis caused by communityassociated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445-53.
51. Thangarajah T, Neal TJ, Kennedy TD. An unexpected diagnosis of methicillin-resistant Staphylococcus aureus septic arthritis. Orthop Rev 2009; 1:e13.
52. Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, Hammerman W, Mason EO Jr, Kaplan SL. Community-acquired, methicillinresistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2004; 23:701-6
53. Gravet A, Rondeau M, Harf-Monteil C, Grunenberger F, Monteil H, Scheftel JM, et al. Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD. J Clin Microbiol 1999; 37: 4012–9.
54. Lo J YC. Laboratory Diagnosis of CA-MRSA. The Hong Kong Medical Diary 2007; 12:1-3.
55. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disc diffusion tests; Twenty-Third Informational Supplement. CLSI document M100-S232. CLSI 2013.
56. Laboratory detection of oxacillin/methicillin resistant Staphylococcus aureus.[Internet] Centers for Disease Control and Prevention (2010), Available at : http:www.cdc.gov/mrsa/lab/lab-detection.html.
57. Matouskova I, Janout V. Current knowledge of methicillin-resistant Staphylococcus aureus and community-associated methicillin resistant Staphylococcus aureus. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008; 152:191-202.
58. Aires-de-Sousa M, Boye K, de Lencastre H, Deplano A, Enright MC, Etienne J, et al. High interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter study. J Clin Microbiol 2006; 44:619-21
59. Chacko J, Kuruvila M, Bhat GK. Factors affecting the nasal carriage of methicillin resistant Staphylococcus aureus in human immunodeficiency virus-infected patients. Indian J Medical Microbiol 2009; 27:146-8.
|